Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial
Published Online: 2005-06-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Andreas Polychronis•David Peston•David Vigushin•Dharsha Shivapatham•Dimitri Hadjiminas•Emma Beresford•H Dudley Sinnett•Hemant Singhal•Janine L Mansi•Jie Jiang•Ken Morrison•Martin J Slade•Nigel Barrett•R Charles Coombes•Sami Shousha•Simak Ali
